in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—12 August 2014
12:56 AM MDT | August 12, 2014 | Deepti Ramesh
Daiichi Sankyo to sell API plant at Akita to Japanese firm Pharmaceutical company Daiichi Sankyo (Tokyo) says that it has reached an agreement with finished dosage forms producer Alfresa Pharma (Osaka, Japan) to sell the active pharmaceutical ingredient (API) plant at Akita, Japan owned by the Daiichi Sankyo Propharma (DSPP; Tokyo) subsidiary, to Alfresa. Financial details of the agreement were not disclosed. The transaction is expected to be completed on 1 April 2015. Daiichi Sankyo is in the process of restructuring its pharma ingredient subsidiaries. The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee